-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.00152.1% Upside
NextCure, Inc. Frequently Asked Questions
-
What analysts cover NextCure, Inc.?
NextCure, Inc. has been rated by research analysts at Piper Sandler in the past 90 days.